Please assess the completion status of the following clinical trial:

Trial Title: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient requiring a hypofractionated irradiation (≥ 3 fractions, dose ≥ 9 Gy per fraction) either for :~* hepatocellular carcinoma or hepatic lesion of metastatic Colorectal Cancer,~* metastasis from melanoma or renal cancer,~* Age ≥ 18 years old,~* Registered with a social security system,~* Signed written informed consent.~Exclusion Criteria:~* Patient treated by chemotherapy, targeted or immunotherapy within 21 days before the first sampling,~* Pregnant or breastfeeding woman,~* Patient under guardianship or tutorship.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Blood samples collection (Type: EXPERIMENTAL): Nine blood samples will be collected in each patient before, during and after radiotherapy treatment.~Interventions :~* Blood samples collection before radiotherapy (T0)~* Blood samples collection during radiotherapy (T1-T3)~* Blood samples collection after radiotherapy (T4-T8)

Based on this trial design, predict the completion outcome and termination type (if applicable).